Abstract:Tumor immunosuppression may assist the immune escape of cancer cells, which promotes tumor metastasis and resistance to chemo-radiotherapy. The therapeutic strategies against tumor immunosuppression mainly focus on blocking immune checkpoint receptors, enhancing T-cell recognition and neutralizing inhibitory molecules. Although immunotherapies based on these strategies have improved the clinical outcomes, immunological nonresponse and resistance are two barriers to tumor eradication. Therefore, there is an urgent need to identify new biomarkers for patient selection and therapeutic targets for the development of combination regimen with immunotherapy. Recent studies have reported that non-protein-coding modulators exhibit important functions in post-transcriptional gene regulation, which subsequently modulates multiple pathophysiological processes, including neoplastic transformation. Differentiated from microRNAs, long non-coding RNAs (lncRNAs) are reported to be involved in various processes of the immune response in the tumor microenvironment (TME) to promote tumor immunosuppression. Currently, studies on tumor immunity regulated by lncRNAs are mainly confined to certain types of cancer cells or stromal cells. Additionally, the majority of studies are focused on the events involved in T cells and myeloid-derived suppressor cells (MDSCs). Although the reported studies have indicated the significance of lncRNAs in immunotherapy, the lack of comprehensive studies prevents us from exploring useful lncRNAs. In the current review, we have summarized the roles of lncRNAs in tumor immune response, and highlighted major lncRNAs as potential biomarkers or therapeutic targets for clinical application of immunotherapy.

Effects of Non-Coding RNA on Regulatory T Cells and Implications for Treatment of Immunological Diseases

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

The Role of MicroRNAs in Regulatory T Cells

MicroRNA Networks in Regulatory T Cells

Regulatory Effects of Long Non-coding RNAs on Th17/Treg Differentiation and Imbalance

Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

Improving regulatory T cell-based therapy: insights into post-translational modification regulation

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges

Research Progress on Regulatory T Cells and Their Relationship with Autoimmune Diseases

Current status and perspectives of regulatory T cell-based therapy

Advance of Immunoregulatory Mechanisms of Long Non-Coding Rna

Immunomodulatory Role and Therapeutic Potential of Non-Coding RNAs Mediated by Dendritic Cells in Autoimmune and Immune Tolerance-Related Diseases

Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment

Long non-coding RNA: Multiple effects on the differentiation, maturity and cell function of dendritic cells

The Effect of FOXP3+ Regulatory T Cells on Infectious and Inflammatory Diseases

New Insights into Regulatory T Cells: Exosome- and Non-Coding Rna-Mediated Regulation of Homeostasis and Resident Treg Cells

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

Regulating Regulatory T Cells to Achieve Transplant Tolerance.

Different Subpopulations of Regulatory T Cells in Human Autoimmune Disease, Transplantation, and Tumor Immunity

Targeting tumor-infiltrating tregs for improved antitumor responses

Non-coding RNAs: Key Players in T Cell Exhaustion